# Antler Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antler-bio

- Industry: Biotechnology
- Headquarters: Dublin, Ireland
- Website: www.antlerbio.com
- Total disclosed funding: $4.3M
- Latest round: Seed (Jun 15, 2025)
- Investors on record: 2

## About

Founded in 2020 and based in Dublin, Ireland, Antler Bio Ltd. focuses on understanding and manipulating gene expression that uses genetic data to help farmers improve animal health, productivity, and sustainability. In June 2025, Antler Bio Ltd raised USD 4.3 million in venture funding led by new investor The First Thirty Ventures, with participation from other new investors Endgame Capital and Generation-RE. The company’s portfolio of services includes RNA-seq and ATAC-seq data analysis for a variety of genomes, such as human, mouse, horse, and bovine. The key features of genomic services include RNA-seq analysis with gene count generation and quality control, as well as ATAC-seq analysis with calling and quality control. The firm provides its flagship technology, an epigenomics platform that detects the presence of genes and measures activity and expression levels, providing a comprehensive understanding of an animal's genetic profile. Antler Bio enhances the productivity, fertility, and welfare of animals while addressing health disorders and reducing greenhouse gas emissions. The company also focuses on the challenges faced by farmers in the livestock industry, such as food security, rising costs, and the need for sustainability. This approach empowers farmers with actionable insights, enabling them to make informed decisions at both individual animal and farm levels. In addition, the company employs analytics, including bioinformatics, machine learning, and artificial intelligence, to analyze data and deliver insights to farmers through a platform. The organization generates revenue through its pricing structure, with options for both standard and priority services, including RNA-seq data analysis, which starts at EUR 120 for the standard service setup fee, while ATAC-seq analysis begins at EUR 240. The company will use the June 2025 funding to expand EpiHerd across Europe.

## Funding rounds

- Seed, Jun 15, 2025, $4.3M — Endgame Capital, The First Thirty

## Investors

- Endgame Capital (https://capitalatlas.ai/funds/endgame-capital) — Seed
- The First Thirty (https://capitalatlas.ai/funds/the-first-thirty) — Seed